-
Homoharringtonine: From Ribosome to Assay Design
2026-09-07
Homoharringtonine is a cytotoxic alkaloid whose translation-blocking biology connects leukemia research with SARS-CoV-2 antiviral research. This evidence-aware guide focuses on assay architecture, interpretation, and the limits of translating ribosome inhibition across disease models.
-
PINK1 Loss, Mitochondrial Iron, and Colon Tumors
2026-09-07
The reference study identifies mitochondrial iron accumulation as a targetable consequence of PINK1 deficiency in colorectal tumor models. By integrating transcriptomics, iron imaging, pharmacological chelation, and MCU manipulation, it connects defective mitophagy with iron-driven tumor growth and supports further investigation of iron-reducing strategies in PINK1-low disease.
-
Dorsomorphin 2HCl: AMPK Inhibitor Workflows
2026-09-05
Dorsomorphin 2HCl is a practical loss-of-function tool for testing whether AMPK activation explains metabolic phenotypes, while its BMP activity supports complementary osteogenesis and iron-regulation studies. This guide connects formulation, cell assays, liver-model controls, and troubleshooting to the probiotic alcoholic-steatosis findings reported in 2025.
-
AAPH Oxidation of Hazelnut Protein Gels
2026-09-04
Jiang et al. compared AAPH, malondialdehyde, and hydrogen peroxide as distinct oxidation treatments for hazelnut proteins, linking oxidation route with solubility, interfacial functionality, and gel-network structure. The results show that oxidation is not uniformly detrimental: AAPH produced concentration-dependent changes, whereas hydrogen peroxide improved several properties while weakening water retention and emulsion stability.
-
Phillygenin in Diabetic Nephropathy: Mechanistic Evidence
2026-09-04
The reference study shows that phillygenin protects against diabetic nephropathy in mouse podocytes and db/db mice by coordinating suppression of TLR4/MyD88/NF-κB inflammation with activation of PI3K/AKT/GSK3β signaling. Its integrated cell, transcriptomic, biochemical, and animal-model design provides mechanistic support for reducing cytokine production, podocyte apoptosis, and albuminuria, while still requiring validation in human and pharmacological studies.
-
Angiotensin III in RAAS and Receptor Assays
2026-09-03
Angiotensin III combines defined sequence, high HPLC purity, and strong aqueous compatibility for reproducible RAAS, receptor-signaling, and peptide-binding experiments. Its N-terminally truncated structure also makes it useful for separating aldosterone, pressor, receptor, and spike–receptor effects in comparative assay panels.
-
α-Linolenic Acid: Applied Research Workflows
2026-09-03
Build reproducible ALA experiments for lipid metabolism, cardiovascular signaling, inflammation, and cancer biology. This practical guide combines solvent handling, dose-response design, cross-domain interpretation, and troubleshooting for reliable cell-based and in vivo research.
-
Lipo3K Transfection Reagent for ccRCC Studies
2026-09-02
Lipo3K Transfection Reagent is a lipid transfection reagent for DNA, siRNA, and mRNA delivery across adherent, suspension, and difficult-to-transfect cells. Its two-component system supports plasmid nuclear entry, serum-compatible workflows, and low-toxicity downstream analysis for gene expression studies and RNA interference research.
-
α-Linolenic Acid: From Lipid Substrate to Translation
2026-09-02
α-Linolenic Acid (ALA) is more than an essential omega-3 fatty acid: it is a tractable substrate for testing how lipid flux becomes a cellular phenotype. This article connects ALA-centered metabolic, cardiovascular, inflammatory, and cancer research with a recent arachidonic acid study while maintaining a clear boundary between mechanistic opportunity and demonstrated evidence.
-
Cefepime Beyond Coverage: A Translational Lens
2026-09-01
Cefepime (BMY-28142) is more than a broad-spectrum comparator: it is a mechanistically defined tool for connecting cell-wall inhibition, resistance biology, central nervous system exposure, and neurotoxicity-aware model design. This perspective shows how translational researchers can use Cefepime to build more predictive bacterial infection models while keeping product handling, evidence boundaries, and clinical relevance clearly separated.
-
Dual-Action Inhibitors and p38α Dephosphorylation
2026-09-01
The reference preprint identifies a dual-action mechanism in which selected kinase inhibitors both suppress p38α catalytic activity and accelerate WIP1-mediated removal of the activation-loop phosphate. Biochemical assays and X-ray structures connect this effect to an inhibitor-stabilized activation-loop conformation, suggesting a strategy for designing kinase inhibitors that also promote target-selective dephosphorylation.
-
Physiological Fruit Abscission in Actinidia arguta
2026-08-31
A 2025 study combined comparative transcriptomics, hormone measurements, exogenous treatments, and transient gene overexpression to explain physiological fruit abscission in Actinidia arguta. Its findings connect auxin–ethylene imbalance with jasmonate, brassinosteroid, ABA, and cell-wall remodeling pathways, offering mechanistic targets for reducing yield loss.
-
Chloroquine BA1002 for Reliable Cell Assays
2026-08-31
A scenario-driven guide to using Chloroquine (SKU BA1002) in viability, proliferation, cytotoxicity, and autophagy studies. It connects formulation, dose selection, orthogonal readouts, and interpretation to improve reproducibility without overstating what cell-based data can prove.
-
Dlin-MC3-DMA: Designing Smarter RNA LNPs
2026-08-30
Dlin-MC3-DMA is an ionizable cationic liposome lipid for tunable siRNA and mRNA delivery. This article connects its pH-responsive chemistry with machine-learning-guided LNP design and practical assay decisions.
-
E. coli Uracil-DNA Glycosylase (UDG) Guide
2026-08-29
E. coli Uracil-DNA Glycosylase (UDG), SKU K1107, removes uracil residues from single- and double-stranded DNA and can support PCR product contamination elimination. It is intended for research workflows involving DNA, not RNA, oligonucleotides shorter than six bases, diagnostic testing, or medical applications.